These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10498063)

  • 1. Does raloxifene reduce breast cancer risk?
    Mattimoe D; Newton W
    J Fam Pract; 1999 Sep; 48(9):659-60. PubMed ID: 10498063
    [No Abstract]   [Full Text] [Related]  

  • 2. Does raloxifene reduce postmenopausal women's risk of breast cancer?
    Han RK; Pimlott N; Heisey R
    Can Fam Physician; 2000 Jan; 46():77-80. PubMed ID: 10660790
    [No Abstract]   [Full Text] [Related]  

  • 3. Raloxifene: a selective estrogen receptor modulator.
    Scott JA; Da Camara CC; Early JE
    Am Fam Physician; 1999 Sep; 60(4):1131-9. PubMed ID: 10507743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Smart' estrogens emerging.
    Harv Heart Lett; 1998 Mar; 8(7):4-5. PubMed ID: 9516317
    [No Abstract]   [Full Text] [Related]  

  • 5. Until there's more information, caution advised in using tamoxifen or raloxifene for breast cancer prevention.
    Mayo Clin Health Lett; 1998 Jul; 16(7):4. PubMed ID: 9663019
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.
    Cummings SR; Eckert S; Krueger KA; Grady D; Powles TJ; Cauley JA; Norton L; Nickelsen T; Bjarnason NH; Morrow M; Lippman ME; Black D; Glusman JE; Costa A; Jordan VC
    JAMA; 1999 Jun; 281(23):2189-97. PubMed ID: 10376571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of breast cancer.
    Dalton RR; Kallab AM
    South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raloxifene and its role in breast cancer prevention.
    Eng-Wong J; Zujewski JA
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):523-32. PubMed ID: 15270657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is raloxifene the answer to the HRT story?
    Apgar B
    Am Fam Physician; 1999 Sep; 60(4):1092, 1095. PubMed ID: 10507739
    [No Abstract]   [Full Text] [Related]  

  • 10. Raloxifene: a new class of anti-estrogens for the prevention of osteoporosis.
    Kupecz D
    Nurse Pract; 1998 Sep; 23(9):91-3. PubMed ID: 9778672
    [No Abstract]   [Full Text] [Related]  

  • 11. HRT and SERMS--increasing benefit, reducing risk?
    Jackson G
    Int J Clin Pract; 1998; 52(1):3. PubMed ID: 9536557
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene.
    Martino S; Cauley JA; Barrett-Connor E; Powles TJ; Mershon J; Disch D; Secrest RJ; Cummings SR;
    J Natl Cancer Inst; 2004 Dec; 96(23):1751-61. PubMed ID: 15572757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.
    Vogel VG
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4413s-4418s; discussion 4411s-4412s. PubMed ID: 11916233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Raloxifene: a new molecule for the prevention of menopausal osteoporosis].
    Oliaro A
    Minerva Ginecol; 1998 Mar; 50(3):XII-XIII. PubMed ID: 9595915
    [No Abstract]   [Full Text] [Related]  

  • 15. Smart estrogens may decrease heart-attack risk.
    Harv Heart Lett; 1998 Sep; 9(1):2. PubMed ID: 9734243
    [No Abstract]   [Full Text] [Related]  

  • 16. [SERM--selective estrogen receptor modulators].
    Kønig KB; Eiken PA; Schwarz P
    Ugeskr Laeger; 2001 Apr; 163(15):2129-33. PubMed ID: 11332210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raloxifene: designer estrogen for preventing postmenopausal osteoporosis.
    Park L; Evans MF
    Can Fam Physician; 1999 May; 45():1191-3. PubMed ID: 10349062
    [No Abstract]   [Full Text] [Related]  

  • 18. [Estrogen agonists, especially raloxifene, in the treatment of osteoporosis].
    Lips P; Netelenbos JC
    Ned Tijdschr Geneeskd; 1996 Jun; 140(23):1215-7. PubMed ID: 8700270
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs can reduce the incidence of breast cancer: now what?
    Wozniak TF; Eppes PG; Wilson CT
    Del Med J; 1999 Sep; 71(9):387-9. PubMed ID: 10584440
    [No Abstract]   [Full Text] [Related]  

  • 20. [New prevention strategies against breast cancer and cervical carcinoma. What can you advice to your patients].
    Kammerer S
    MMW Fortschr Med; 2003 Dec; 145(50):4-6. PubMed ID: 14963962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.